Combined intrauterine and ovarian pregnancy mimicking ovarian malignant tumor: imaging findings.
Ovarian mass combined with pancreatic neoplasm in pregnancy: A rare case report and literature review.
Lee YJ, Kim SW, Kim Y.
J Obstet Gynaecol Res. 2022 Jan;48(1):244-250. doi: 10.1111/jog.15085. Epub 2021 Nov 2.
Ovarian cancer in pregnancy.
Fruscio R, de Haan J, Van Calsteren K, Verheecke M, Mhallem M, Amant F.
Best Pract Res Clin Obstet Gynaecol. 2017 May;41:108-117. doi: 10.1016/j.bpobgyn.2016.09.013. Epub 2016 Oct 1.
PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis.
Yun BS, Won S, Kim JH, Lee N, Kim M, Kim MK, Kim ML, Jung YW, Kim JY, Seong SJ, Shin E.
J Ovarian Res. 2022 Apr 6;15(1):41. doi: 10.1186/s13048-022-00975-5.
Ovarian cancer.
Barber HR.
CA Cancer J Clin. 1986 May-Jun;36(3):149-84. doi: 10.3322/canjclin.36.3.149.
NIRVANA-1: maintenance therapy with niraparib versus niraparib-bevacizumab in patients with advanced ovarian cancer.
Sghaier S, Corbaux P, Ray-Coquard I, Lim MC, Hasegawa K, Nieuwenhuysen EV, Gonzalez A, Raspagliesi F, Freyer G.
Future Oncol. 2023 Aug;19(25):1715-1727. doi: 10.2217/fon-2023-0167. Epub 2023 Aug 31.
Chemotherapy in pregnancy.
Brewer M, Kueck A, Runowicz CD.
Clin Obstet Gynecol. 2011 Dec;54(4):602-18. doi: 10.1097/GRF.0b013e318236e9f9.
Epithelial ovarian cancer.
Ng JS, Low JJ, Ilancheran A.
Best Pract Res Clin Obstet Gynaecol. 2012 Jun;26(3):337-45. doi: 10.1016/j.bpobgyn.2011.12.005. Epub 2012 Jan 24.
Clinical effect of mifepristone on patients with ovarian cancer in pregnancy.
Shang L, Wang Y, Lyu Y.
Pak J Pharm Sci. 2019 Jan;32(1(Special)):421-426.
Risks and Benefits of Salpingectomy at the Time of Sterilization.
Castellano T, Zerden M, Marsh L, Boggess K.
Obstet Gynecol Surv. 2017 Nov;72(11):663-668. doi: 10.1097/OGX.0000000000000503.
Ovarian yolk sac tumor associated with pregnancy: a case report and review of the literature.
Miyamoto M, Takano M, Goto T, Kato M, Sasaki N, Furuya K.
Eur J Gynaecol Oncol. 2014;35(6):738-40.
